DNA leaping 7% today. Some more information:

Ginkgo Bioworks Holdings Inc - Class A (DNA) is trading 7.7% higher at $3.76 today. The promising biotech company saw strong price moves in the premarket and continued to surge in the trading day. The share price is moving on an earnings revenue beat of $67.01M and strong earnings guidance for the rest of the year.

Ginkgo Bioworks Holdings Inc - Class A has been trading between a 52-week high of $15.86 and a 52-week low of $2.09, and is currently trading near the bottom of that range. The stock has a market cap of $4.26 Billion.

Ginkgo Bioworks is building a platform to enable customers to program cells as easily as they can program computers. The company's cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

StophJS - 6 upvotes - source
Super glad I bought DNA on earnings and then sold at a 6k loss only to have it run later

DovahkiinAF - 3 upvotes - source
you could buy synthetic biotech (DNA) or quantum computing (IONQ), but you picked “dying brick-and-mortar bathroom store” 🤡

ando421 - 3 upvotes - source
$SNAP $TSLA $BBBY $FCEL $DNA LMK

Ok-Squirrel1616 - 3 upvotes - source
DNA earnings in, 7mil volume after market. Can’t decide if those are all pumping and dumping or if it’s gonna 🚀

YungBird - 3 upvotes - source
I'm bullish AF on DNA

OneTrueDweet - 2 upvotes - source
Leaps on DNA surprisingly affordable…

TylerInHiFi - 2 upvotes - source
It’s in their DNA, shit

TheDeHymenizer - 2 upvotes - source
no where near the long term value or flexibility? World needed COVID tests so Foundry produced them. World might not need them in a year but might need something like Nitrogen for fertilizers. Your COVID companies can't pivot and start making those, DNA can.

Over-Meet-9892 - 2 upvotes - source
Moving $DNA up and up 🚀🚀🚀